A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer

BACKGROUND: Gene expression can be employed for the discovery of prognostic gene or multigene signatures cancer. In this study, we assessed the prognostic value of a 35-gene expression signature selected by pathway and machine learning based methods in adjuvant therapy-linked glioblastoma multiforme...

Descripción completa

Detalles Bibliográficos
Autores principales: Fatai, Azeez A., Gamieldien, Junaid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883543/
https://www.ncbi.nlm.nih.gov/pubmed/29614978
http://dx.doi.org/10.1186/s12885-018-4103-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883543/
https://www.ncbi.nlm.nih.gov/pubmed/29614978
http://dx.doi.org/10.1186/s12885-018-4103-5

Ejemplares similares